News

Company News

Home > News > Company News
04/21
2021
03/30
2021
At the beginning of the new year, we start a new chapter. On February 18, the seventh day of the first lunar month of the Year of the Ox, CR Capital Management held a simple but festive commencement ceremony in Shenzhen, Hong Kong and Beijing simultaneously to celebrate the formal commencement in th
03/17
2021
On March 15, EyeYon Medical announced the completion of a USD 25 million Series C financing jointly led by CR-CP Life Science Fund and a global leading enterprise in the ophthalmology industry. Other participants in this round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securi
03/11
2021
On March 11, Carl Qin, the General Manager at CR Capital Management, and his delegation involving Ni Bing, managing director of CR Everbright Health Industry FOF, and Dr. Gong Chunhe, executive director, investigated Hunan Kexin Health Industry Group. Chen Lihong, president of Kexin Group, Hu Zhenhu
03/10
2021
Recently, a delegation led by Yao Xiaosheng, general manager of the Capital Operation Department at Yuexiu Group, as well as chairman and president of Yuexiu Capital, visited CR Capital Management. The two sides exchanged views on the business development and management mode of a diversified industr
02/19
2021
On February 18, New Horizon Health was officially listed on the Hong Kong Stock Exchange (stock code: 6606.HK). In this public offering, New Horizon Health was 4,133 times oversubscribed, and 76.598 million shares were issued worldwide. The international offering and the Hong Kong public offering we
02/05
2021
In December 2020, the Asia Food Growth Fund I announced that it had completed the acquisition of a controlling stake in Singapore’s Viz Branz Group. Founded in 1988, Viz Branz is a well-known instant cereal and beverage company in China and Southeast Asia. Headquartered in Singapore, it has factor
02/05
2021
On January 18, 2021, Extreme Vision, an artificial intelligence (AI) vision algorithm marketplace, held a "Series C1 Financing Press Conference" in Shenzhen and announced the completion of its Series C1 financing. Many media, such as investorscn.com, the Nanfang Daily, Sina, the Guangdong section of
02/05
2021
On January 15, 2021, CR Capital Management, Shenzhen Angel Investment Guiding Fund and Great Vigour Capital (兴锐资本) held a kick-off meeting and development planning seminar at the China Resources Tower in Shenzhen for the Runxing Ruihua (Shenzhen) Sci-Tech Achievement Transformation Angel Investment
01/19
2021
Impulse Dynamics, a company focused on the development of devices for the treatment of heart failure, recently announced that it completed a USD 60 million Series D financing
01/13
2021
Recently, TalkingData announced a new round of financing of about USD 100 million. CR Data Fund (Big Data Technology Application Fund) of CR Capital leads the investment in financing as a strategic investor.
01/13
2021
Recently, CR-BECE New Energy Fund (hereinafter referred to as "BECE Fund") of CR Capital Management (hereinafter referred to as "CR Capital") successfully withdrew. Its photovoltaic assets were officially delivered in December 2020, and the IRR of project investment exceeded 20%. As the fund manager
01/11
2021
On December 25, 2020, CR Capital Management and China Orient held the cooperation forum and project signing ceremony in Shenzhen China Resources Financial Building.
01/11
2021
On December 22, 2020, CR Capital Management signed a strategic cooperation agreement with China RE Capital Management Co., Ltd.in Shenzhen.
12/31
2020
CR Capital Management was enlisted on the Praise List at the 2020 China FOF Summit! On December 20, the 2020 China FOF Summit announced this list, sponsored by china-fof.com! CR Capital Management received two awards!
12/31
2020
CR Capital Management received two awards on the 2020 Ranking List of CVINFO for Guangdong-Hong Kong-Macao Greater Bay Area, after winning several awards from China Bridge, Zero2IPO and Golden Investment Prize this year!
12/14
2020
In 2020, a group of young investors who started their investment careers with the advancement of mobile Internet are embracing their 40s. Some of them have become the mainstays of large enterprises, while others have set up their own businesses, forming unique venture capital forces.
11/27
2020
On November 10, 2020, New Horizon Health filed to go public on the HKEX, with Goldman Sachs and UBS as joint sponsors. New Horizon Health (the Company) was established in November 2015, focusing on home-based early screening and testing services for high-risk cancers in China.
11/27
2020
CR Capital Management successfully hosted the 13th Five-Year Strategic Review Meeting and the 14th Five-Year Strategic Planning Seminar in Shenzhen and Hong Kong on November 13 - 14, 2020. The participants included the management team of the Company, MDs of the funds, directors of different departme
11/26
2020
On 19 November, Hang Seng Indexes Company Limited announced the half-yearly review results for the Hang Seng Shanghai-Shenzhen-Hong Kong Innovative Drug Select 50 Index for the period ended 31 October 2020. Dirui Industrial Co., Ltd. (the Company) and other 12 stocks were approved to be included in
Site Map Disclaimer Privacy Clause Contact Us
2017 COPYRIGHT © CR Capital Management   粤ICP备18110148号 Technical Support: CR DIGITAL